Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Immunocompetent models of brain parenchymal and leptomeningeal metastasis

ABSTRACT: Immunocompetent models of brain parenchymal and leptomeningeal metastasis

PROVIDER: PRJNA913954 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22816100_1.fastq.gz	Fastqsanger.gz
	SRR22816100_2.fastq.gz	Fastqsanger.gz
	SRR22816101_1.fastq.gz	Fastqsanger.gz
	SRR22816101_2.fastq.gz	Fastqsanger.gz
	SRR22816102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

Immunocompetent models of brain parenchymal and leptomeningeal metastasis

Project description:Using iterative in vivo selection strategy, we generated a series of mouse metastatic lines with increased tropism for brain parenchyma or leptomeninges, to faithfully recapitulate the hallmarks of human disease.

2023-03-27 | GSE221358 | GEO

Genes that mediate leptomeningeal metastasis from breast and lung solid tumor primaries

Project description:Little is understood about the gene expression changes that underlie cancer spread to the cerebrospinal fluid, or leptomeningeal metastasis. Using four cancer cell line models, we empolyed iterative in vivo selection to generate subpopulations of these cell lines able to access the leptomeningeal space and grow once there. We compared the gene expression profile of the terminally selected cells or "Lep" cells with that of the parental or "Par" cells, as well as that of an intermediate stage of in vivo selection or "Int" cells. Analyses for brain parenchymal metastatic derivatives or "BrM" cells were included for comparison.

2017-05-10 | GSE83132 | GEO

Phenotypic states of leptomeningeal metastasis

Project description:Phenotypic states of leptomeningeal metastasis

| PRJNA564289 | ENA

Cerebrospinal fluid microRNA profile in leptomeningeal metastasis patients [LM vs non-LM]

Project description:This study aimed to identify specific CSF miRNAs for diagnosing and monitoring leptomeningeal metastasis with lung adenocarcinoma. In discovery phase, we performed miRNA microarray analysis in CSF samples from leptomeningeal metastasis patients and non-leptomeningeal metastasis controls.

2020-02-26 | GSE125191 | GEO

Cerebrospinal fluid microRNA profile in leptomeningeal metastasis patients [pre- vs post-treatment]

Project description:This study aimed to identify specific CSF miRNAs for diagnosing and monitoring leptomeningeal metastasis with lung adenocarcinoma. In discovery phase, we performed miRNA microarray analysis in matched CSF samples from leptomeningeal metastasis patients at diagnosis and after initial leptomeningeal metastasis-directed therapy.

2020-02-26 | GSE125192 | GEO

RNA profiling of CSF resident macrophages and monocyte-macrophages from leptomeningeal metastasis mice

Project description:We investigated the functional effect of dura-derived leptomeningeal matastasis (LM)-associated macrophages (dLAMs) on the cerebrospinal fluid (CSF) niche during LM outgrowth. Using lung cancer leptomeningeal metastasis models of Cx3cr1CreER:mTmG mice with tamoxifen administration, we achieved dLAMs and monocyte-macrophages via fluorescence-activated cell sorting (FACS). Then we performed bulk RNAseq analysis for these two cell populations.

2024-07-24 | GSE267325 | GEO

Parenchymal border macrophages regulate CSF flow dynamics [leptomeningeal macs]

Project description:Parenchymal border macrophages regulate CSF flow dynamics [leptomeningeal macs]

| PRJNA778203 | ENA

Phenotypic states of leptomeningeal metastasis

Project description:Leptomeningeal metastasis (LM), or spread of cancer cells into the cerebrospinal fluid, is characterized by a rapid onset of debilitating neurological symptoms and markedly bleak prognosis. The lack of reproducible in vitro and in vivo models has prevented development of novel, LM-specific therapies. Although LM allows for longitudinal sampling of floating cancer cells with a spinal tap, attempts to culture patient-derived leptomeningeal cancer cells have not been successful. We therefore employ leptomeningeal derivatives of human breast and lung cancer cell lines that reproduce both floating and adherent phenotypes of human LM in vivo and in vitro. We introduce a trypsin/EDTA-based fractionation method to reliably separate the two cell subsets and demonstrate that in vitro cultured floating cells have decreased proliferation rate, lower ATP content, and are enriched in distinct metabolic signatures. Long-term fractionation and transcriptomic analysis suggest a high degree plasticity between the two phenotypes in vitro. Floating cells colonize mouse leptomeninges more rapidly and associate with shortened survival. In addition, patients harboring LM diagnosed with CSF disease alone succumbed to the disease earlier than patients with adherent (MRI-positive) disease. Together, these data support mechanistic evidence of a metabolic adaptation that allows cancer cells to thrive in their natural environment but leads to death in vitro.

2020-01-21 | GSE137020 | GEO

CSF proteomics of leptomeningeal metastasis mouse models

Project description:To unbiasedly identify the crucial factors produced by CSF, we utilized liquid chromatography-mass spectrometry (LC-MS) based label-free quantitative proteomic platform on the CSF, respectively collected in control and leptomeningeal metastasis mice. Cell-free CSF was collected from Ctrl or LM mice at day12 after LLC-LeptoM inoculation, followed by proteomics analysis. n=15 mice for three samples per group, CSF pooled from five mice per sample.

2024-07-25 | PXD054256 |

Single-cell atlas of human leptomeningeal metastasis

Project description:Single-cell atlas of human leptomeningeal metastasis

| PRJNA633130 | ENA